MAPT and Alzheimer disease: A diverse range of in vivo models-including pharmacologically induced models, transgenic animal models, and in vitro neuronal cell cultures-each with distinct advantages for exploring various pathological mechanisms of AD, such as tau pathology, Aβ aggregation, synaptic dysfunction, and neuroinflammation.